| Dignity Health Medical Group - Dominican, A Service Of Dignity Health | |
|
1820 41st Ave Suite D Capitola CA 95010-2516 | |
| (831) 476-3000 | |
| (831) 476-9009 |
| Full Name | Dignity Health Medical Group - Dominican, A Service Of Dignity Health |
|---|---|
| Speciality | Clinic/center - Multi-specialty |
| Location | 1820 41st Ave, Capitola, California |
| Authorized Official Name and Position | Theresa M Hylen (CHIEF FINANCIAL OFFICER) |
| Authorized Official Contact | 9168512559 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Dignity Health Medical Group - Dominican, A Service Of Dignity Health 3000 Q St Sacramento CA 95816-7058 Ph: (916) 733-5701 | Dignity Health Medical Group - Dominican, A Service Of Dignity Health 1820 41st Ave Suite D Capitola CA 95010-2516 Ph: (831) 476-3000 |
| NPI Number | 1053517797 |
|---|---|
| Provider Enumeration Date | 06/21/2007 |
| Last Update Date | 11/18/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053517797 | NPI | - | NPPES |
| ZZZ50287Z | Other | BSCA | |
| GR0091681 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
News Archive
Pulmo BioTech Inc. has announced that early indications are that its PulmoBind product candidate has the potential for early diagnosis of Pulmonary Hypertension in the pediatric population. PH is a potentially life threatening and crippling disease; it is also very hard to diagnose.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has shipped its first commercial order of DAVANAT® to PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. The $200,000 shipment of DAVANAT® will be used by PROCAPS to qualify its vial filling process.
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
A third of patients with advanced or metastatic melanoma will achieve an objective response to treatment with the programmed cell death protein inhibitor pembrolizumab, suggest KEYNOTE-001 findings, regardless of whether they have previously been treated with ipilimumab.
› Verified 9 days ago
Dignity Health Medical Group - Dominican, A Service Of Dignity Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 528 Capitola Ave, Capitola, CA 95010 Phone: 831-475-1630 Fax: 831-475-1629 | |
Bayview Gastroenterology Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4145 Clares St, Ste A, Capitola, CA 95010 Phone: 831-662-9999 Fax: 831-662-9998 | |
Western Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 528 Capitola Ave, Capitola, CA 95010 Phone: 831-475-1630 Fax: 831-475-1629 | |
Wellness Aesthetics Central Coast Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4450 Capitola Rd Ste 105, Capitola, CA 95010 Phone: 831-325-0202 | |
Whole Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1595 38th Ave, Capitola, CA 95010 Phone: 831-621-1848 Fax: 831-621-1804 |